Cosmo Bio Company,Limited (TSE: 3386)
Health Care · Health Care Providers & Services · JP
¥1,254.00
+0.48% today · +6.3% 1Y
Cosmo Bio Company,Limited (TSE: 3386) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $44.95M and employs 182 people.
Over the last twelve months the share price has gained 6.3%, trading between 1.08K and 1.49K.
Tweenvest scores Cosmo Bio Company,Limited across four factors: quality 67/100, value 45/100, growth 32/100, dividend 90/100. Its strongest factor is dividend.
3386 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $44.95M
- Revenue (TTM)
- $69.38M
- P/E
- 19.56
- EPS
- 64.10
- Dividend yield
- 3.99%
- Beta (5Y)
- 0.18
- 52-week high
- ¥1,486.00
- 52-week low
- ¥1,083.00
- Avg volume (3M)
- —
- Shares outstanding
- 5.70M
- Employees
- 182
- Next earnings
- —
About Cosmo Bio Company,Limited
Cosmo Bio Company, Limited is a key player in the life science research sector, involved in the global import, export, manufacturing, marketing, and distribution of essential biotools. Their extensive product line includes biochemical reagents, specialized kits, scientific instruments, analytical software, and diagnostic products. Among their research reagents, they offer a wide spectrum such as antibodies, antigens, bioactive substances, enzymes, peptides, amino acids, various chemicals, carbohydrates, lipids, and components derived from viruses and bacteria. They also provide crucial detection reagents, cell and tissue culture systems, and gene analysis solutions. In terms of instrumentation, Cosmo Bio supplies electrophoresis apparatuses, cell culture labware, gene manipulation systems, and data analysis software. Beyond products, the company delivers valuable services like drug discovery support, custom research, and clinical diagnostics. A significant part of their operation involves the development and manufacturing of proprietary cell and cell culture products. This includes a range of specialized cells such as adipose tissue, bone, cartilage, tooth, pancreas, liver function, cardiovascular, immune, and mesenchymal stem cells, in addition to feeder cells, tumor cell lines, coating reagents, and macrophage-related products. They also produce various assay kits for measurement, staining, detection, and purification. Furthermore, they offer specialized biotechnology research equipment, including constant-temperature transport containers, aluminum block heat insulation devices, and dew condensation prevention glass plates, alongside consigned services for custom peptide synthesis and antibody production. Serving a diverse clientele of laboratories, research institutes, and life science education and testing organizations, Cosmo Bio distributes its products through its own outlets in Japan and an international network of sales agents. The company was founded in Tokyo, Japan, in 1978, where its headquarters remain.
- ISIN
- JP3298700000
- Founded
- 1978
- Listed since
- Sep 27, 2005
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $357.92B | $398.76 | +2.22% |
| CVS Health CorporationNYSE: CVS | $120.36B | $94.11 | +1.17% |
| McKesson CorporationNYSE: MCK | $101.88B | $873.79 | +1.73% |
| HCA Healthcare, Inc.NYSE: HCA | $92.93B | $429.24 | +0.01% |
| Elevance Health, Inc.NYSE: ELV | $87.32B | $402.63 | +0.52% |
| The Cigna GroupNYSE: CI | $74.11B | $280.45 | +1.06% |
| Cencora, Inc.NYSE: COR | $61.78B | $323.77 | +1.80% |
| Cardinal Health, Inc.NYSE: CAH | $54.04B | $232.37 | +1.25% |
Figures last refreshed Aug 18, 2026.